Back to Archived News
CPA Lacasse Offers Clients Chemical Structure and Biological Sequence Patent Research and Analysis
Thursday, April 24, 2008
CPA Lacasse Global Research has announced the launch of sophisticated gene and protein sequence analysis capabilities to its industry leading pharmaceutical and biotech clients. CPA Lacasse is a premier provider of global patent services offering a comprehensive suite of research products for life sciences clients both large and small.
Biological therapeutics and diagnostic tools form the basis of many cutting edge medical treatments today and are quickly becoming one of the most prolific areas for patent filing. It is critical for life sciences companies to have a complete understanding of their freedom to operate in this highly complex and litigious space. Using best in class tools, CPA Lacasse searches nucleic acid and polypeptide sequences to capture relevant patents and scholarly journal articles typically not identified by standard keyword and classification search methods.
Randy Lacasse, CEO of CPA Lacasse Global Research said, "We support our clients in the life sciences industry by delivering sophisticated portfolio and market analysis, allowing them to strategically allocate valuable R&D resources to bring life-saving treatments to market as quickly as possible."
CPA Lacasse offers a full range of patent research services for its pharmaceutical and biotechnology clients including patentability, infringement and validity studies. CPA Lacasse’s team of highly trained patent researchers provides key competitive intelligence spanning the product development lifecycle from drug discovery and development to regulatory approval and market launch.
Many corporations and law firms leverage CPA Lacasse patent services as a key strategic enabler. We provide the means to increase bandwidth in our client’s legal, R&D, and business development groups while helping to streamline their innovation pipelines to eliminate unnecessary and expensive R&D spending. With full understanding of the competitive patent landscape, key decision makers can identify white space opportunities for growth while avoiding costly pitfalls into crowded markets.
"CPA’s heritage has been providing clients with sophisticated intellectual property solutions. As CPA expands its offerings into general legal services, the patent research division becomes even more critical as they assist our clients in IP litigation matters," said Chris Veator, Executive VP Legal Services at CPA.
About CPA (www.cpaglobal.com)
A multi-shore company with offices in seven countries, CPA has been solving complex challenges for leading law firms and corporations worldwide since 1969. The firm is a leading provider of outsourced IP, Litigation Support, and Contract Management solutions, helping clients realize value by managing risk, cost and capacity.
Back to Archived News